Targeting Treatment-Resistant Breast Cancer Stem Cells with FKBPL and Its Peptide Derivative, AD-01, via the CD44 Pathway
McClements, L., Yakkundi, A., Papaspyropoulos, A., Harrison, H., Ablett, M. P., Jithesh, P. V., McKeen, H. D., Bennett, R., Donley, C., Kissenpfennig, A., McIntosh, S., McCarthy, H. O., O'Neill, E., CVolume:
19
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-13-0595
Date:
July, 2013
File:
PDF, 1.23 MB
english, 2013